This journal is not listed in the SCIE, SSCI, AHCI, ESCI, Scopus or JCR 2024 lists. That does not make it unreliable, but check its indexing, peer review and fees carefully.
How to spot predatory journals →01Impact factor
Impact factor of Leukemia & lymphoma/Leukemia and lymphoma (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Leukemia & lymphoma/Leukemia and lymphoma published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is not listed in JCR 2024, so it has no official Journal Impact Factor from Clarivate; the value above is how often its recent papers are cited.
Rank in its subject categories
- Hematologyrank 55 of 104 journals
- Oncologyrank 218 of 347 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Leukemia & lymphoma/Leukemia and lymphoma
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Leukemia & lymphoma/Leukemia and lymphoma is not listed in JCR 2024, so it has no JCR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Is your paper a fit for Leukemia & lymphoma/Leukemia and lymphoma?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
02Review time
Review time of Leukemia & lymphoma/Leukemia and lymphoma
Each paper took a different time. The green box holds the middle half of the papers and the dark line is the median; the whiskers reach the fastest 10% and the slowest 10%. Plan with the whole spread, not only the median.
Half of the research articles Leukemia & lymphoma/Leukemia and lymphoma published between Mar 2026 and Oct 2026 were accepted within 82 days of submission, and the middle half took between 61 and 118 days. This time includes peer review and any revision rounds. Papers that were rejected are not counted, because only published papers carry these dates.
In Oncology, Leukemia & lymphoma/Leukemia and lymphoma ranks 29 of 125 journals by review time (1 = fastest). See the fastest-review journals in Oncology →
03Fee waivers
APC waivers and discounts for Leukemia & lymphoma/Leukemia and lymphoma
We have not found a published waiver policy for this journal's publisher. Ask the editorial office before you submit, and compare publishers that do waive the APC in the APC waiver checker.
Waivers apply to fully open access journals. If Leukemia & lymphoma/Leukemia and lymphoma is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Who funds research published in Leukemia & lymphoma/Leukemia and lymphoma
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
04Indexing
Indexing of Leukemia & lymphoma/Leukemia and lymphoma
| List | Status |
|---|---|
| Science Citation Index Expanded (SCIE) | Not listed |
| Social Sciences Citation Index (SSCI) | Not listed |
| Arts & Humanities Citation Index (AHCI) | Not listed |
| Emerging Sources Citation Index (ESCI) | Not listed |
| Scopus | Not listed |
| Journal Citation Reports 2024 | Not listed |
- ISSN
- 1026-8022
- eISSN
- 1029-2403
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
05How to submit
How to submit to Leukemia & lymphoma/Leukemia and lymphoma
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Leukemia & lymphoma/Leukemia and lymphoma accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Leukemia & lymphoma/Leukemia and lymphoma is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
06Reviewer comments
Reviewer comments and rejection reasons for Leukemia & lymphoma/Leukemia and lymphoma
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Planning to submit to Leukemia & lymphoma/Leukemia and lymphoma? A Manuscript Audit by a PhD reviewer in your area checks your paper for the issues reviewers raise most often.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds07Same subject
Hematology journals with a similar impact factor*
The journals next to Leukemia & lymphoma/Leukemia and lymphoma when the 103 journals of Hematology in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 51 | Transfusion | 1.82 | SCIE | Subscription |
| 52 | Transfusion Medicine and Hemotherapy | 1.80 | SCIE | Fully open access |
| 53 | Blood Purification | 1.78 | SCIE | Subscription |
| 54 | Clinical and Applied Thrombosis/Hemostasis | 1.78 | SCIE | Fully open access |
| 56 | Journal of Blood Medicine | 1.75 | ESCI | Fully open access |
| 57 | Microcirculation | 1.67 | SCIE | Subscription |
| 58 | Blood | 1.62 | SCIE | Subscription |
| 59 | Mediterranean Journal of Hematology and Infectious Diseases | 1.59 | SCIE | Fully open access |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is Leukemia & lymphoma/Leukemia and lymphoma right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,109 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
08Questions
Frequently asked questions
How long is the review time of Leukemia & lymphoma/Leukemia and lymphoma?
Based on 198 research articles Leukemia & lymphoma/Leukemia and lymphoma published from Mar 2026 to Oct 2026, the median time from submission to acceptance was 82 days, and half of them were accepted between 61 and 118 days. After acceptance, papers appeared online after a median of 16 days. Data updated October 2026. Individual papers can take longer, especially with major revisions.
What is the impact factor of Leukemia & lymphoma/Leukemia and lymphoma?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Leukemia & lymphoma/Leukemia and lymphoma is 1.76: papers it published in the two previous years were cited 1.76 times on average in a year. The journal is not listed in JCR 2024, so it has no official Clarivate Journal Impact Factor.
What is the h-index of Leukemia & lymphoma/Leukemia and lymphoma?
The h-index of Leukemia & lymphoma/Leukemia and lymphoma is 117 (October 2026): 117 of its papers have each been cited at least 117 times. Its i10-index is 6,986.
What is the quartile of Leukemia & lymphoma/Leukemia and lymphoma?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Leukemia & lymphoma/Leukemia and lymphoma is not listed in JCR 2024, so it has no JCR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Leukemia & lymphoma/Leukemia and lymphoma indexed in Scopus?
Leukemia & lymphoma/Leukemia and lymphoma is not listed in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Leukemia & lymphoma/Leukemia and lymphoma an SCIE journal?
Leukemia & lymphoma/Leukemia and lymphoma is not listed in SCIE or the other Web of Science indexes, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Leukemia & lymphoma/Leukemia and lymphoma in Journal Citation Reports (JCR)?
Leukemia & lymphoma/Leukemia and lymphoma is not listed in the JCR 2024 list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Who funds research published in Leukemia & lymphoma/Leukemia and lymphoma?
36% of 200 recent research articles in Leukemia & lymphoma/Leukemia and lymphoma name a funder; the funders named most often are National Natural Science Foundation of China, Bristol Myers Squibb, National Institutes of Health.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Journal of Bacteriology
- Heliyon
- Chemical Communications
- Medical Physics
- Journal of Dairy Science
- Journal of Applied Polymer Science
- Molecules
- Thin Solid Films
- Ceramics International
- Journal of Cleaner Production
- Journal of the Franklin Institute
- International Journal of Hydrogen Energy
- Journal of Physical Chemistry B
- Applied Surface Science
Browse all journals: indexing, impact factor and reviewer comments →